Global Binge Eating Disorder Drug Market Research Report 2021

1 Binge Eating Disorder Drug Market Overview

• 1.1 Product Overview and Scope of Binge Eating Disorder Drug
• 1.2 Binge Eating Disorder Drug Segment by Type
  • 1.2.1 Global Binge Eating Disorder Drug Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Antidepressants
  • 1.2.3 Anticonvulsants
  • 1.2.4 Anti-obesity Medications
• 1.3 Binge Eating Disorder Drug Segment by Application
  • 1.3.1 Binge Eating Disorder Drug Sales Comparison by Application: (2021-2027)
  • 1.3.2 Retail Pharmacies
  • 1.3.3 Hospital Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Binge Eating Disorder Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Binge Eating Disorder Drug Revenue 2016-2027
  • 1.4.2 Global Binge Eating Disorder Drug Sales 2016-2027
  • 1.4.3 Binge Eating Disorder Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Binge Eating Disorder Drug Market Competition by Manufacturers

• 2.1 Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Binge Eating Disorder Drug Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Binge Eating Disorder Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Binge Eating Disorder Drug Market Competitive Situation and Trends
  • 2.5.1 Binge Eating Disorder Drug Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Binge Eating Disorder Drug Players Market Share by Revenue
  • 2.5.3 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Binge Eating Disorder Drug Retrospective Market Scenario by Region

• 3.1 Global Binge Eating Disorder Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Binge Eating Disorder Drug Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Binge Eating Disorder Drug Market Facts & Figures by Country
  • 3.3.1 North America Binge Eating Disorder Drug Sales by Country
  • 3.3.2 North America Binge Eating Disorder Drug Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Binge Eating Disorder Drug Market Facts & Figures by Country
  • 3.4.1 Europe Binge Eating Disorder Drug Sales by Country
  • 3.4.2 Europe Binge Eating Disorder Drug Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Binge Eating Disorder Drug Sales by Region
  • 3.5.2 Asia Pacific Binge Eating Disorder Drug Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Binge Eating Disorder Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Binge Eating Disorder Drug Sales by Country
  • 3.6.2 Latin America Binge Eating Disorder Drug Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Binge Eating Disorder Drug Sales by Country
  • 3.7.2 Middle East and Africa Binge Eating Disorder Drug Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Binge Eating Disorder Drug Historic Market Analysis by Type

• 4.1 Global Binge Eating Disorder Drug Sales Market Share by Type (2016-2021)
• 4.2 Global Binge Eating Disorder Drug Revenue Market Share by Type (2016-2021)
• 4.3 Global Binge Eating Disorder Drug Price by Type (2016-2021)

5 Global Binge Eating Disorder Drug Historic Market Analysis by Application

• 5.1 Global Binge Eating Disorder Drug Sales Market Share by Application (2016-2021)
• 5.2 Global Binge Eating Disorder Drug Revenue Market Share by Application (2016-2021)
• 5.3 Global Binge Eating Disorder Drug Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Roche Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Chronos Therapeutics
  • 6.2.1 Chronos Therapeutics Corporation Information
  • 6.2.2 Chronos Therapeutics Description and Business Overview
  • 6.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Chronos Therapeutics Product Portfolio
  • 6.2.5 Chronos Therapeutics Recent Developments/Updates
• 6.3 Heptares
  • 6.3.1 Heptares Corporation Information
  • 6.3.2 Heptares Description and Business Overview
  • 6.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Heptares Product Portfolio
  • 6.3.5 Heptares Recent Developments/Updates
• 6.4 Novo Nordisk
  • 6.4.1 Novo Nordisk Corporation Information
  • 6.4.2 Novo Nordisk Description and Business Overview
  • 6.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Novo Nordisk Product Portfolio
  • 6.4.5 Novo Nordisk Recent Developments/Updates
• 6.5 Omeros Corp
  • 6.5.1 Omeros Corp Corporation Information
  • 6.5.2 Omeros Corp Description and Business Overview
  • 6.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Omeros Corp Product Portfolio
  • 6.5.5 Omeros Corp Recent Developments/Updates
• 6.6 Sunovion Pharmaceuticals
  • 6.6.1 Sunovion Pharmaceuticals Corporation Information
  • 6.6.2 Sunovion Pharmaceuticals Description and Business Overview
  • 6.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Sunovion Pharmaceuticals Product Portfolio
  • 6.6.5 Sunovion Pharmaceuticals Recent Developments/Updates
• 6.7 Opiant Pharmaceuticals
  • 6.6.1 Opiant Pharmaceuticals Corporation Information
  • 6.6.2 Opiant Pharmaceuticals Description and Business Overview
  • 6.6.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Opiant Pharmaceuticals Product Portfolio
  • 6.7.5 Opiant Pharmaceuticals Recent Developments/Updates

7 Binge Eating Disorder Drug Manufacturing Cost Analysis

• 7.1 Binge Eating Disorder Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
• 7.4 Binge Eating Disorder Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Binge Eating Disorder Drug Distributors List
• 8.3 Binge Eating Disorder Drug Customers

9 Binge Eating Disorder Drug Market Dynamics

• 9.1 Binge Eating Disorder Drug Industry Trends
• 9.2 Binge Eating Disorder Drug Growth Drivers
• 9.3 Binge Eating Disorder Drug Market Challenges
• 9.4 Binge Eating Disorder Drug Market Restraints

10 Global Market Forecast

• 10.1 Binge Eating Disorder Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Binge Eating Disorder Drug by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Type (2022-2027)
• 10.2 Binge Eating Disorder Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Binge Eating Disorder Drug by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Application (2022-2027)
• 10.3 Binge Eating Disorder Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Binge Eating Disorder Drug by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Binge Eating Disorder Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List